上海医药：关于普瑞巴林胶囊获得新加坡药品注册证书的公告

Core Viewpoint - Shanghai Pharmaceuticals announced that its subsidiary, Changzhou Pharmaceutical Factory, received a drug registration certificate from the Health Sciences Authority (HSA) of Singapore for the drug Pregabalin capsules, which has been approved for market launch [1]. Group 1 - The drug Pregabalin capsules have been officially approved for sale in Singapore [1]. - The approval was granted by the Health Sciences Authority (HSA) of Singapore [1].